Medical device manufacturer TriReme Medical, LLC had standing to pursue a claim to correct the inventorship of three patents owned by competitor AngioScore, Inc., based on an assignment from a physician who allegedly contributed to the development of the angioplasty balloon catheter claimed in the patents, the U.S. Court of Appeals for the Federal Circuit has ruled (TriReme Medical, LLC v. AngioScore, Inc., February 5, 2016, Dyk, T.). The federal district court in San Francisco erred in concluding on a motion to dismiss that the physician’s consulting agreement with AngioScore precluded him from owning any rights in the patents at issue.

A full summary of this case has been published on Kluwer IP Law.


Kluwer IP Law
This page as PDF